Does RITLECITINIB Cause Therapeutic product effect incomplete? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Therapeutic product effect incomplete have been filed in association with RITLECITINIB (Litfulo). This represents 8.5% of all adverse event reports for RITLECITINIB.
122
Reports of Therapeutic product effect incomplete with RITLECITINIB
8.5%
of all RITLECITINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From RITLECITINIB?
Of the 122 reports.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITLECITINIB. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does RITLECITINIB Cause?
Drug ineffective (259)
Condition aggravated (85)
Off label use (82)
Headache (70)
Diarrhoea (49)
Product dose omission issue (45)
Alopecia (44)
Fatigue (36)
Urticaria (36)
Acne (35)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which RITLECITINIB Alternatives Have Lower Therapeutic product effect incomplete Risk?
RITLECITINIB vs RITODRINE
RITLECITINIB vs RITONAVIR
RITLECITINIB vs RITUXAN
RITLECITINIB vs RITUXIMAB
RITLECITINIB vs RITUXIMAB-ABBS